Filing Details

Accession Number:
0001209191-22-003192
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-13 16:33:26
Reporting Period:
2022-01-11
Accepted Time:
2022-01-13 16:33:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1868734 Cincor Pharma Inc. CINC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245624 James Healy C/O Cincor Pharma, Inc
200 Clarendon Street, 6Th Floor
Boston MA 02116
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-11 5,248,949 $0.00 5,248,949 No 4 C Indirect By Sofinnova Venture Partners X, L.P.
Common Stock Acquisiton 2022-01-11 325,000 $16.00 5,573,949 No 4 P Indirect By Sofinnova Venture Partners X, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Sofinnova Venture Partners X, L.P.
No 4 P Indirect By Sofinnova Venture Partners X, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2022-01-11 13,571,428 $0.00 3,991,596 $0.00
Common Stock Series B Preferred Stock Disposition 2022-01-11 4,275,000 $0.00 1,257,353 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
  2. The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.